Weekly Biotech Catalysts

Every Sunday: the coming week of FDA decision dates, Phase 2 and 3 trial completions and earnings, plus the past week of delays, discontinuations, FDA decisions and new timelines from SEC filings.

Biotech Catalysts This Week: FDA Decisions, Readouts & Earnings (Sep 6–Sep 13, 2026)

September 6, 2026 ·

No FDA decision dates or earnings reports fall in this week. The nearest regulatory events on the Run-up Radar are NUVL’s NDA decision in 12 days and MIRM’s in 20 days. Among last week’s biotech gainers, SMMT rose 17% on 2.9 times its average volume. 📡 Run-up Radar Highlights Stocks entering the pre-catalyst window with […]

Biotech Catalysts This Week: FDA Decisions, Readouts & Earnings (Aug 30–Sep 6, 2026)

August 30, 2026 ·

Here’s what’s on the biotech calendar for August 30–September 6: 0 FDA decision dates, 15 trial catalysts, and 0 earnings reports from tracked companies. 🧪 Trial Catalysts & Milestones APGE, 2026-09-01: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Immunogenicity… OSTX, 2026-09-01: Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return […]

Biotech Catalysts This Week: FDA Decisions, Readouts & Earnings (Aug 23–Aug 30, 2026)

August 23, 2026 ·

Here’s what’s on the biotech calendar for August 23–August 30: 2 FDA decision dates, 4 trial catalysts, and 1 earnings reports from tracked companies. 💊 FDA Decisions (PDUFA Dates) Date Ticker Drug Indication Type 2026-08-25 JAZZ — sBLA 2026-08-25 ZYME — adults with previously treated NDA 🧪 Trial Catalysts & Milestones OSTX, 2026-08-26: Palbociclib and […]

Biotech Catalysts This Week: FDA Decisions, Readouts & Earnings (Aug 16–Aug 23, 2026)

August 16, 2026 ·

Here’s what’s on the biotech calendar for August 16–August 23: 1 FDA decision dates, 1 trial catalysts, and 1 earnings reports from tracked companies. 💊 FDA Decisions (PDUFA Dates) Date Ticker Drug Indication Type 2026-08-22 CAPR — rare diseases BLA 📊 Earnings This Week CADL, 2026-08-19 (est. EPS -0.24) 📡 Run-up Radar Highlights Stocks entering […]

Biotech Catalysts This Week: FDA Decisions, Readouts & Earnings (Aug 9–Aug 16, 2026)

August 9, 2026 ·

Here’s what’s on the biotech calendar for August 9–August 16: 0 FDA decision dates, 3 trial catalysts, and 13 earnings reports from tracked companies. 🧪 Trial Catalysts & Milestones ACRV, 2026-08-12: Phase 1 Study of ACR-2316 in Specific Advanced Solid Tumors 📊 Earnings This Week SLS, 2026-08-10 (est. EPS -0.05) SPRO, 2026-08-10 (est. EPS -0.17) […]

Biotech Catalysts This Week: FDA Decisions, Readouts & Earnings (Aug 2–Aug 9, 2026)

August 2, 2026 ·

Here’s what’s on the biotech calendar for August 2–August 9: 0 FDA decision dates, 2 trial catalysts, and 5 earnings reports from tracked companies. 🧪 Trial Catalysts & Milestones BIIB, 2026-08-06: A Study to Learn About the Safety of BIIB142 and How it is Processed in the Body of Healthy Adult Participants Aged 18 to […]

Biotech Catalysts This Week: FDA Decisions, Readouts & Earnings (Jul 26–Aug 2, 2026)

July 26, 2026 ·

Here’s what’s on the biotech calendar for July 26–August 2: 1 FDA decision dates, 14 trial catalysts, and 1 earnings reports from tracked companies. 💊 FDA Decisions (PDUFA Dates) Date Ticker Drug Indication Type 2026-07-29 OTLK — Wet AMD <P STYLE=”font: 10pt Times New Roma BLA 🧪 Trial Catalysts & Milestones OSTX, 2026-07-30: Intrathecal Combination […]

Biotech Catalysts This Week: FDA Decisions, Readouts & Earnings (Jul 19–Jul 26, 2026)

July 19, 2026 ·

Here’s what’s on the biotech calendar for July 19–July 26: 0 FDA decision dates, 2 trial catalysts, and 0 earnings reports from tracked companies. 📡 Run-up Radar Highlights Stocks entering the pre-catalyst window with the strongest setups (full radar is a Premium feature): CORT: Phase 2, Recruiting in 13 days, score 68/100 ACIU: Phase 1, […]

Biotech Catalysts This Week: FDA Decisions, Readouts & Earnings (Jul 12–Jul 19, 2026)

July 12, 2026 ·

Here’s what’s on the biotech calendar for July 12–July 19: 1 FDA decision dates, 3 trial catalysts, and 0 earnings reports from tracked companies. 💊 FDA Decisions (PDUFA Dates) Date Ticker Drug Indication Type 2026-07-17 CELC — a significant number of patients with HR+/HER2- advanced bre NDA 📡 Run-up Radar Highlights Stocks entering the pre-catalyst […]

Biotech Catalysts This Week: FDA Decisions, Readouts & Earnings (Jul 5–Jul 12, 2026)

July 5, 2026 ·

Here’s what’s on the biotech calendar for July 5–July 12: 2 FDA decision dates, 0 trial catalysts, and 0 earnings reports from tracked companies. 💊 FDA Decisions (PDUFA Dates) Date Ticker Drug Indication Type 2026-07-07 VERA — IgAN in adults BLA 2026-07-11 CORT — Platinum-Resistant Ovarian Cancer <P STYLE=”margin- NDA 📡 Run-up Radar Highlights Stocks […]

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.